ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $495,798 | +4.5% | 37,732 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $474,541 | -3.6% | 37,662 | -0.2% | 0.00% | 0.0% |
Q1 2023 | $492,272 | -52.0% | 37,722 | -35.1% | 0.00% | -66.7% |
Q4 2022 | $1,024,602 | -17.4% | 58,084 | -28.7% | 0.00% | 0.0% |
Q3 2022 | $1,240,000 | +36.9% | 81,424 | +33.3% | 0.00% | +50.0% |
Q2 2022 | $906,000 | -39.2% | 61,062 | -7.8% | 0.00% | -33.3% |
Q1 2022 | $1,491,000 | +12.7% | 66,212 | -7.7% | 0.00% | +50.0% |
Q4 2021 | $1,323,000 | +36.7% | 71,702 | -1.0% | 0.00% | 0.0% |
Q3 2021 | $968,000 | -27.8% | 72,401 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $1,340,000 | -49.4% | 72,401 | -58.9% | 0.00% | -40.0% |
Q1 2021 | $2,647,000 | -28.1% | 176,287 | -30.9% | 0.01% | -28.6% |
Q4 2020 | $3,682,000 | +295.5% | 255,017 | +123.1% | 0.01% | +250.0% |
Q3 2020 | $931,000 | +20.3% | 114,321 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $774,000 | -3.9% | 114,321 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $805,000 | -28.3% | 114,321 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $1,122,000 | -20.1% | 114,321 | -10.6% | 0.00% | -25.0% |
Q3 2019 | $1,404,000 | -24.6% | 127,841 | -20.1% | 0.00% | -20.0% |
Q2 2019 | $1,862,000 | +21.9% | 160,073 | 0.0% | 0.01% | +25.0% |
Q1 2019 | $1,527,000 | +7.4% | 160,073 | +8.5% | 0.00% | 0.0% |
Q4 2018 | $1,422,000 | -38.1% | 147,553 | -8.5% | 0.00% | -33.3% |
Q3 2018 | $2,299,000 | +29.8% | 161,299 | +9.3% | 0.01% | +20.0% |
Q2 2018 | $1,771,000 | -2.8% | 147,553 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $1,822,000 | -15.1% | 147,553 | 0.0% | 0.01% | -16.7% |
Q4 2017 | $2,147,000 | +2.2% | 147,553 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $2,100,000 | +11.5% | 147,553 | 0.0% | 0.01% | +20.0% |
Q2 2017 | $1,883,000 | -44.6% | 147,553 | -45.0% | 0.01% | -50.0% |
Q1 2017 | $3,401,000 | +24.2% | 268,225 | 0.0% | 0.01% | +25.0% |
Q4 2016 | $2,739,000 | -25.2% | 268,225 | -3.6% | 0.01% | -27.3% |
Q3 2016 | $3,663,000 | +3.7% | 278,145 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $3,532,000 | +9.7% | 278,145 | +14.2% | 0.01% | -8.3% |
Q1 2016 | $3,219,000 | -14.1% | 243,642 | 0.0% | 0.01% | -14.3% |
Q4 2015 | $3,747,000 | +24.0% | 243,642 | 0.0% | 0.01% | +16.7% |
Q3 2015 | $3,021,000 | -9.4% | 243,642 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $3,333,000 | +14.4% | 243,642 | 0.0% | 0.01% | +20.0% |
Q1 2015 | $2,914,000 | -11.5% | 243,642 | -5.5% | 0.01% | 0.0% |
Q4 2014 | $3,291,000 | -4.8% | 257,692 | 0.0% | 0.01% | -9.1% |
Q3 2014 | $3,457,000 | -16.4% | 257,692 | 0.0% | 0.01% | -15.4% |
Q2 2014 | $4,136,000 | -10.0% | 257,692 | +1.1% | 0.01% | -13.3% |
Q1 2014 | $4,598,000 | +8.6% | 254,998 | -6.9% | 0.02% | +15.4% |
Q4 2013 | $4,234,000 | +4.0% | 273,841 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $4,072,000 | +15.0% | 273,841 | +0.1% | 0.01% | +8.3% |
Q2 2013 | $3,541,000 | – | 273,684 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |